United States · Bill · HR
H.R. 3317 (107th)
Medicare Drug Cost Savings Act of 2001
Introduced
16 November 2001
Last action
28 November 2001 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Sen. Baldwin, Tammy [D-WI], Rep. Woolsey, Lynn C. [D-CA-6], Rep. Kleczka, Gerald D. [D-WI-4], Rep. Barrett, Thomas M. [D-WI-5], Rep. Matsui, Robert T. [D-CA-3], Rep. Frank, Barney [D-MA-4], Rep. Mink, Patsy T. [D-HI-2], Barbara Lee, Rep. Kilpatrick, Carolyn C. [D-MI-13], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Hilliard, Earl F. [D-AL-7], Rep. Evans, Lane [D-IL-17], Rep. McCarthy, Carolyn [D-NY-4], Rep. Allen, Thomas H. [D-ME-1], Rep. Stark, Fortney Pete [D-CA-9], Earl Blumenauer, JAMES LANGEVIN, Rep. Thurman, Karen L. [D-FL-5]
Subjects
Healthcare, Taxation
Source updated
19 August 2025
Summary
Medicare Drug Cost Savings Act of 2001 - Amends title XVIII (Medicare) of the Social Security Act to provide Medicare coverage of self-administered drugs used as a replacement for certain covered drugs. Prohibits a carrier or fiscal intermediary from requiring the substitution of a self-administered drug for an intravenously-administered drug or drug therapy if, in the judgment of the physician of the individual diagnosed with a condition for which the drug or drug therapy has been prescribed, intravenous-administration of the drug or drug therapy is more appropriate or effective to treat the individual's condition.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
16 November 2001
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
16 November 2001
Introduced
Introduced in House
Source: IntroReferral
16 November 2001
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
16 November 2001
Introduced
Introduced in House
Source: IntroReferral
28 November 2001
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 16 November 2001 · Official file
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 16 November 2001
Introduced in House (PDF)
Introduced in House · EN · 16 November 2001
Introduced in House
summary · EN · 16 November 2001
Sponsors
- Sen. Baldwin, Tammy [D-WI] · D · Sponsor
- Rep. Woolsey, Lynn C. [D-CA-6] · D · Sponsor
- Rep. Kleczka, Gerald D. [D-WI-4] · D · Sponsor
- Rep. Barrett, Thomas M. [D-WI-5] · D · Sponsor
- Rep. Matsui, Robert T. [D-CA-3] · D · Sponsor
- Rep. Frank, Barney [D-MA-4] · D · Sponsor
- Rep. Mink, Patsy T. [D-HI-2] · D · Sponsor
- Barbara Lee · D · Sponsor
- Rep. Kilpatrick, Carolyn C. [D-MI-13] · D · Sponsor
- Rep. Schakowsky, Janice D. [D-IL-9] · D · Sponsor
- Rep. Hilliard, Earl F. [D-AL-7] · D · Sponsor
- Rep. Evans, Lane [D-IL-17] · D · Sponsor
- Rep. McCarthy, Carolyn [D-NY-4] · D · Sponsor
- Rep. Allen, Thomas H. [D-ME-1] · D · Sponsor
- Rep. Stark, Fortney Pete [D-CA-9] · D · Cosponsor
- Earl Blumenauer · D · Cosponsor
- JAMES LANGEVIN · D · Cosponsor
- Rep. Thurman, Karen L. [D-FL-5] · D · Cosponsor
- · hsif00 · Standing
- · hswm00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/107th-congress/house-bill/3317
- Open data entity: https://api.congress.gov/v3/bill/107/hr/3317
- us · 107-hr-3317 · source updated 19 August 2025